|

Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants

RECRUITINGSponsored by University Hospital Tuebingen
Actively Recruiting
SponsorUniversity Hospital Tuebingen
Started2023-12-27
Est. completion2026-09
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06291311

Summary

This is a prospective, single-center, observational proof-of-principle clinical trial at the Department of Women's Health of the University Hospital Tübingen.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Inclusion criteria for NIPP treatment

  * Age ≥ 18 years
  * mRNA or DNA-based virus detection by smear (also external findings)
  * Clearly visible transformation zone of the cervix and margins of the lesions corresponding to T1/T2
  * Written informed consent to participate in the study
* Inclusion criteria for control group

  * Age ≥ 18 years
  * Swab-based mRNA or DNA-based virus detection (also external findings)
  * Clearly visible transformation zone of the cervix corresponding to T1/T2
  * Written informed consent to participate in the study

Exclusion criteria:

The following exclusion criteria apply to both groups of patients (NIPP treatment and control group).

* Transformation zone not fully visible
* Evidence of invasive disease
* Serious cardiovascular diseases

Conditions3

CancerCervical CancerHPV Infection

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.